NeuLion Reports Fiscal 2016 Revenue of $99.8 Million

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
91
NeuLion Reports Fiscal 2016 Revenue of $99.8 Million

PLAINVIEW, NY --(Marketwired - March 01, 2017) - NeuLion , Inc. ( TSX : NLN ), a leading technology product and service provider that specializes in the digital video broadcasting, distribution and monetization of live and on-demand content to Internet-enabled devices, today reported its financial results for the fourth quarter and fiscal year ended December 31, 2016.

Q4 2016 Financial Highlights

(Comparisons made between fiscal Q4 2016 and fiscal Q4 2015 results, unless otherwise noted)

  • GAAP revenue of $25.5 million, down 8%
  • NeuLion® Digital Platform revenue of $17.5 million, down 12%
  • Operating loss of $1.8 million versus operating income of $1.8 million
  • Ongoing Share Repurchase Program resulted in an additional 2.1 million shares purchased and cancelled

Fiscal Year 2016 Financial Highlights

(Comparisons made between fiscal 2016 and fiscal 2015 results, unless otherwise noted)

  • GAAP revenue increased to $99.8 million, up 6%
  • NeuLion Digital Platform revenue increased to $67.9 million, up 3%
  • Operating loss of $0.2 million versus operating loss of $1.9 million
  • Cash totaled $41.9 million at December 31, 2016
  • 6.1 million shares were purchased and cancelled under the Share Repurchase Program initiated in April 2016

"We made significant progress this year implementing our long-term growth strategy, enhancing the NeuLion Digital Platform, and expanding our global presence and business in Europe and Asia," said Roy Reichbach, President and Chief Executive Officer. "We have begun to see tangible results of our expanded sales team in Europe and the integration of Saffron Digital, and we are securing new sales opportunities, which enhances the breadth of our new business pipeline. Also, we are opening up new, global market opportunities. These are important strategic steps taken to further solidify our strong foundation for sustained growth."

Mr. Reichbach added, "With our depth of content partners, new market opportunities and laser focus on quality and the customer experience, we are strategically positioned to take advantage of market trends that are increasingly driving consumers away from the traditional television model. We entered 2017 in a strong position to build and diversify our global customer base while providing excellent OTT experiences to consumers and value to our shareholders."

Q4 2016 Operational Highlights

  • Delivered UFC® 205 in HD and 4K over the top ("OTT"), the first UFC event in New York since the lifting of the state ban on professional mixed martial arts
  • Announced an expanded partnership with Coliseum Sports Media, to deliver live and on-demand rugby action throughout Asia on RugbyPass
  • Unveiled enhanced personalization services on the NeuLion Digital Platform, to assist content owners in driving new subscriber activations and reducing customer churn
  • Licensed MainConcept codecs to MAGIX for use in their VEGAS video editing product line
  • Formed a partnership with Insight TV to provide a new, OTT Ultra HD entertainment platform with native Ultra HD digital content utilizing the NeuLion Digital Platform

Q4 2016 Financial Review

Total GAAP revenue was $25.5 million for the fourth quarter of 2016 ("Q4 2016"), a decrease of 8% over the prior year period. NeuLion Digital Platform revenues declined 12% to $17.5 million in Q4 2016, from $19.8 million for the prior year period. NeuLion's consumer electronics licensing and MainConcept revenue streams were $8.0 million in both Q4 2016 and the prior year period.

Non-GAAP Revenue declined 18% to $25.6 million in Q4 2016, compared to the same period a year ago. The change was primarily due to decreases in consumer electronics licensing and MainConcept revenue streams.

Adjusted EBITDA decreased to $1.7 million in Q4 2016 from $8.8 million for the prior year period, due to a decrease of $5.8 million in both GAAP and Non-GAAP Revenue. Please refer to the below table for the reconciliation of GAAP Revenue to Non-GAAP Revenue and Consolidated Net Income (Loss) to and Adjusted EBITDA.

Cost of revenue was $5.2 million, or 20% of revenue, in Q4 2016, compared to $5.4 million, or 19% of revenue, in the prior year period. Selling, general and administrative expenses, including stock-based compensation, were $14.7 million in Q4 2016, increasing 11% from $13.2 million in the prior year period. Research and development expenses decreased 7% to $5.1 million in Q4 2016, from $5.5 million for the prior comparable period, primarily following a reduction in headcount resulting from redundancy associated with the acquisition of DivX Corporation in 2015. Operating loss was $1.8 million in Q4 2016, compared to operating income of $1.8 million in the prior year period. Net loss was $0.3 million, or a net loss of $0.00 per basic and diluted share in Q4 2016, compared to a net income of $32.8 million, or a net income of $0.11 per basic and diluted share, in the prior year period.

Share Repurchase Program

On March 8, 2016, NeuLion announced that its Board of Directors had authorized the repurchase of up to $10 million of its common stock over the next 12 months through a normal course issuer bid ("NCIB") for up to 14,109,057 shares of common stock. On March 24, 2016, NeuLion announced that it had received the TSX's approval to commence the NCIB, and that the NCIB would commence on April 1, 2016. Since initiating the program, NeuLion has purchased 7.7 million shares of common stock at a total cost of $6.5 million through February 28, 2017.

Use of Non-GAAP Financial Information

In addition to NeuLion's U.S. GAAP results, this press release also includes disclosure of certain non-GAAP financial measures, as such term is used by the Securities and Exchange Commission. NeuLion defines "Non-GAAP Revenue" as GAAP revenues before purchase accounting adjustments as a result of the acquisition of DivX. NeuLion defines "Adjusted EBITDA" as consolidated net income (loss) before interest, income taxes, depreciation and amortization, purchase accounting adjustments, stock-based compensation, acquisition-related expenses, gain on revaluation of convertible note derivative and foreign exchange gain (loss). Adjusted EBITDA is a key measure used by management to evaluate NeuLion's results and make strategic decisions about the company, including potential acquisitions. Management believes this measure is useful to investors because it is an indicator of operational performance. Because not all companies use identical calculations, NeuLion's presentation of Non-GAAP Revenue and Adjusted EBITDA may not be comparable to similarly titled measures of other companies. These measures do not have any standardized meanings prescribed by U.S. GAAP and therefore are unlikely to be comparable to the calculation of similar measures used by other companies, and should not be viewed as alternatives to measures of financial performance or changes in cash flows calculated in accordance with U.S. GAAP.

Pursuant to the requirements of Regulation G, NeuLion has provided a reconciliation of U.S. GAAP consolidated net income (loss) to Adjusted EBITDA in the below table.

Reconciliation of GAAP Revenue to non-GAAP Revenue  (in thousands) :
                   
  Three months ended,     Year ended,  
  2016   2015     2016   2015  
                           
GAAP Revenue $ 25,528   $ 27,784     $ 99,789   $ 94,043  
                           
Revenue excluded due to purchase accounting   42     3,572       1,057     15,308  
                           
Non-GAAP Revenue $ 25,570   $ 31,356     $ 100,846   $ 109,351  
                           
                           
Reconciliation of GAAP Net Income (Loss) to Adjusted EBITDA (in thousands):
                           
    Three months ended,       Year ended,  
    2016     2015       2016     2015  
                           
Consolidated Net Income (Loss) on a GAAP Basis $ (344 ) $ 32,766     $ (1,753 ) $ 25,916  
                           
Revenue excluded due to purchase accounting   42     3,572       1,057     15,308  
Depreciation and amortization   2,400     1,910       8,899     7,544  
Stock-based compensation   1,085     859       4,573     2,702  
Acquisition-related expenses   7     -       109     359  
Listing-related expenses   -     663       -     663  
Gain on revaluation of convertible note derivative   -     -       -     (507 )
Income tax (benefit) expense   (1,622 )   (31,176 )     1,411     (27,847 )
Investment income (expense) and foreign exchange loss   167     166       94     578  
                           
Adjusted EBITDA $ 1,735   $ 8,760     $ 14,390   $ 24,716  

Quarterly Webcast

NeuLion will host a live webcast tomorrow, March 2, 2017 at 8:30 a.m. ET that can be accessed at http://edge.media-server.com/m/p/sx93bxh8 . In addition, a replay of the webcast will be available for a limited time at http://neulion.com/investor .

Financial Statements and MD&A

SEC Filing: click here

SEDAR Filing: click here

About NeuLion

NeuLion, Inc. ( TSX : NLN ) offers solutions that power the highest quality digital experiences for live and on-demand content in up to 4K on any device. Through its end-to-end technology platform, NeuLion enables digital video management, distribution and monetization for content owners worldwide including the NFL, NBA, World Surf League, Univision Deportes, Euroleague Basketball and others. NeuLion powers the entire video ecosystem for content owners and rights holders, consumer electronic companies, and third party video integrators through its MainConcept business. NeuLion's robust consumer electronics licensing business enables its customers like Sony, LG, Samsung and other to stream secure, high-quality video seamlessly across their consumer devices. NeuLion is headquartered in Plainview, NY. For more information about NeuLion, visit www.NeuLion.com .

Forward-Looking Statements

Certain statements herein are forward-looking statements and represent NeuLion's current intentions in respect of future activities. Forward-looking statements can be identified by the use of the words "will," "expect," "seek," "anticipate," "believe," "plan," "estimate," "expect," and "intend," statements that an event or result "may," "will," "can," "should," "could," or "might" occur or be achieved, and other similar expressions. These statements, in addressing future events and conditions, involve inherent risks and uncertainties. Although the forward-looking statements contained in this release are based upon what management believes to be reasonable assumptions, NeuLion cannot assure readers that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this release and NeuLion assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law. Many factors could cause NeuLion's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including: our ability to derive anticipated benefits from the acquisition of DivX Corporation and Saffron Digital Media; our ability to realize some or all of the anticipated benefits of our partnerships; general economic and market segment conditions; our customers' subscriber levels and financial health; our ability to pursue and consummate acquisitions in a timely manner; our continued relationships with our customers; our ability to negotiate favorable terms for contract renewals; competitor activity; product capability and acceptance rates; technology changes; regulatory changes; foreign exchange risk; interest rate risk; and credit risk. These factors should be considered carefully and readers should not place undue reliance on the forward-looking statements. A more detailed assessment of the risks that could cause actual results to materially differ from current expectations is contained in the "Risk Factors" section of NeuLion's Annual Report on Form 10-K for the fiscal year ended December 31, 2016, which is available on www.sec.gov and filed on www.sedar.com .

Attachment Available: http://www.marketwire.com/library/MwGo/2017/3...958521.pdf
Attachment Available: http://www.marketwire.com/library/MwGo/2017/3...55778b.pdf

CONTACT INFORMATION Press Contact: Chris Wagner Email contact +1 516 622 8357 Investor Relations Contact: Rob Kelly Email contact +1 416 992 4539

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mako Hiraizumi Shines with Silver at Japan Triathlon

Updated Category News Views 115

A Triathlete with Grit and Ambition Mako Hiraizumi didn't just earn a silver medal at the 32nd Japan Triathlon National Championships; she set an example of perseverance and ambition. Rising a notch from her bronze finish last year, Hiraizumi's runner-up achievement at Tokyo's Odaiba Seaside Park is no small feat. Yet, she's not resting on her laurels. This athlete from...

Continue Reading
Paratus Energy Lands Petrobras Tender, Ties Finalizing

Updated Category News Views 25

Seagems Joint Venture Snags Petrobras Contract Let’s dive headfirst into this business update, because this one's got teeth, folks. Petrobras, the big dog in Brazil’s oil arena, has given the green light to Seagems’ bid, a joint venture half-owned by Paratus Energy Services Ltd. The target? A hefty pipe-laying support vessel (PLSV) contract starting in 2028. But...

Continue Reading
PNU and Cellenkos Team Up for Biotech Advancements

Updated Category News Views 13

Paving New Paths in Biotech Collaboration When a university and a biotech company shake hands to bolster their capabilities in the ever-evolving field of clinical trials and cell and gene therapies, investors and industry buffs alike should perk up. The College of Medicine at Princess Nourah bint Abdulrahman University (PNU) has just inked a Memorandum of Understanding...

Continue Reading
Tuya Gears Up for Q3 Financial Results Amid AI Growth

Updated Category News Views 11

Tuya's Third Quarter: What Are We Watching? Alright, folks, Tuya's about to drop their third quarter financial results like it's a hot potato. Circle November 23, 2026, on your calendars. That's when we'll get the goods on whether this AI cloud heavyweight is coasting or crushing it. Conference Call: The Gathering of Numbers The number-crunching brigade kickstarts at 7:30...

Continue Reading
Nevada Organic Phosphate Plans Share Consolidation

Updated Category News Views 24

The Drill Down on Nevada Organic Phosphate's Strategic Moves There's a lot to unpack here as Nevada Organic Phosphate Inc. (CSE: NOP) rolls out its big game plan. They're looking to consolidate shares, flex their financial muscles, and maybe spray some high-octane fuel on their market positioning. Could be a smart move if they pull it off, but that's a big 'if' hanging in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 386

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 584

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
NextVision's Q3 2026: Impressive Growth and Expansion

Updated Category News Views 35

NextVision's financials this quarter are the envy of tech growth companies everywhere. Their Q3 2026 report reads like a thrilling playbook for success. No half-measures here—NextVision has doubled its revenue, slashed costs, and cooked up an operating margin fit for a kingpin. Pushing Revenue to New Heights NextVision didn’t just surpass last year's revenue; it...

Continue Reading
Segway Powersports Ventures into Baja 1000: Ambitions Run High

Updated Category News Views 133

They're gunning for glory in the sands of Baja, folks—Segway Powersports is about to rev up the excitement with its Baja 1000 debut. Never heard before in this legendary race's chronicles, Segway aims to shake up the game with their two brawny Super Villain UTVs. These aren't your run-of-the-pavement ride-ons; they're built for the rough stuff—and if there's a stage...

Continue Reading
Photocure Navigates AssureMDx's Medicare Journey

Updated Category News Views 99

Aiming High with AssureMDx Photocure's got this bladder cancer test called AssureMDx that's at the center of its recent moves after acquiring Vesica Health a few months back. This isn't just any test; it's a urine-based, non-invasive way to snag an early look at bladder cancer. With the FDA's Breakthrough Device tag pinned on, they're not just dipping their toes in—this...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding America's Growing Net Debtor Status: Implications Ahead

Updated Category News Views 181

Shifting Dynamics of America's Net Debtor Status By Jamie McGeever Foreign investment in the U.S. has consistently outnumbered American investments abroad for several decades. This persistent imbalance has raised concerns among analysts about potential repercussions for the dollar's confidence. Despite these warnings, the anticipated crisis regarding this dynamic has not...

Continue Reading
Understanding Doximity's Short Interest Trends and Insights

Updated Category News Views 115

Diving Deeper into Doximity's Short Interest Analysis Doximity (DOCS) has attracted attention in recent financial discussions due to its short interest metrics. Recently, it was reported that the short percent of float for Doximity has decreased by 4.22%. This decline translates to approximately 5.64 million shares sold short, constituting about 4.54% of the company’s...

Continue Reading
Explore the Future of Biologics at Apogee's R&D Day

Updated Category News Views 100

Join Apogee Therapeutics' First Virtual R&D Day Apogee Therapeutics, Inc., a promising clinical-stage biotechnology firm, is poised to present its inaugural virtual Research and Development Day. Scheduled for 10:00 a.m. ET on a soon-to-come date, this event invites those interested in the transformative work happening in the field of biotechnology. Unveiling Innovations...

Continue Reading
Empowering Education: Oklahoma City School Choice Showcase

Updated Category News Views 122

Oklahoma City School Choice Showcase Set to Inspire Families Students from around Oklahoma City are gearing up for a fantastic event at Dove Science Academy, with a heartfelt message highlighting their love for their schools. The exciting gathering will showcase K–12 school choice options available in the state, aligning perfectly with the celebratory spirit of National...

Continue Reading
Experian Uncovers Identity Fraud Trends in 2024 Global Report

Updated Category News Views 661

Comprehensive Insights from the 2024 Global Identity & Fraud Report Experian has unveiled its 2024 Global Identity & Fraud Report, delivering an in-depth analysis of consumer and business responses to prevailing fraud patterns as well as effective mitigation strategies within the financial services sector. This extensive report is backed by data accumulated from over...

Continue Reading